FdaApplication
ANDA 214646
Identifiers
- fda_app_no: ANDA214646
Properties
| Property | Value |
|---|---|
| applicant_name | BE PHARMACEUTICALS AG |
| application_type | ANDA |
| approval_date | 2023-06-06 |
Products (7)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ENOXAPARIN SODIUM (PRESERVATIVE FREE) | ENOXAPARIN SODIUM | 80MG/0.8ML (100MG/ML) | INJECTABLE;SUBCUTANEOUS |
| ENOXAPARIN SODIUM (PRESERVATIVE FREE) | ENOXAPARIN SODIUM | 120MG/0.8ML (150MG/ML) | INJECTABLE;SUBCUTANEOUS |
| ENOXAPARIN SODIUM (PRESERVATIVE FREE) | ENOXAPARIN SODIUM | 60MG/0.6ML (100MG/ML) | INJECTABLE;SUBCUTANEOUS |
| ENOXAPARIN SODIUM (PRESERVATIVE FREE) | ENOXAPARIN SODIUM | 30MG/0.3ML (100MG/ML) | INJECTABLE;SUBCUTANEOUS |
| ENOXAPARIN SODIUM (PRESERVATIVE FREE) | ENOXAPARIN SODIUM | 40MG/0.4ML (100MG/ML) | INJECTABLE;SUBCUTANEOUS |
| ENOXAPARIN SODIUM (PRESERVATIVE FREE) | ENOXAPARIN SODIUM | 100MG/ML (100MG/ML) | INJECTABLE;SUBCUTANEOUS |
| ENOXAPARIN SODIUM (PRESERVATIVE FREE) | ENOXAPARIN SODIUM | 150MG/ML (150MG/ML) | INJECTABLE;SUBCUTANEOUS |
7 products